Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1217)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
223
Price
$325.67
Total Value
$72.62K
Shares Held After
61,805
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
291
Price
$324.88
Total Value
$94.54K
Shares Held After
62,028
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
818
Price
$323.84
Total Value
$264.90K
Shares Held After
62,319
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
374
Price
$323.01
Total Value
$120.81K
Shares Held After
63,137
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
309
Price
$321.82
Total Value
$99.44K
Shares Held After
63,511
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
230
Price
$320.81
Total Value
$73.79K
Shares Held After
63,820
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
109
Price
$320.01
Total Value
$34.88K
Shares Held After
64,050
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
114
Price
$319.03
Total Value
$36.37K
Shares Held After
64,159
% of Holdings
0.2%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
47
Price
$6.29
Total Value
$295.54
Shares Held After
76,226
% of Holdings
0.1%
PepGen Inc. (PEPG)
STRECK PAUL — EVP, Head of R&D
Shares
1,832
Price
$6.23
Total Value
$11.41K
Shares Held After
76,273
% of Holdings
2.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
21,097
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
21,305
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
21,577
% of Holdings
3.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
22,344
% of Holdings
1.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
22,694
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
22,983
% of Holdings
0.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
23,198
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
23,300
% of Holdings
0.5%
BridgeBio Pharma, Inc. (BBIO)
Ellis Andrea — Director
Shares
64,921
Price
$64.87
Total Value
$4.21M
Shares Held After
18,589
% of Holdings
77.7%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
13,941
Price
$36.33
Total Value
$506.46K
Shares Held After
131,196
% of Holdings
9.6%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
4,400
Price
$35.55
Total Value
$156.41K
Shares Held After
145,137
% of Holdings
2.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
265
Price
$325.67
Total Value
$86.30K
Shares Held After
95,695
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
345
Price
$324.88
Total Value
$112.08K
Shares Held After
95,960
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
973
Price
$323.84
Total Value
$315.10K
Shares Held After
96,305
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
444
Price
$323.01
Total Value
$143.42K
Shares Held After
97,278
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
368
Price
$321.82
Total Value
$118.43K
Shares Held After
97,722
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
274
Price
$320.81
Total Value
$87.90K
Shares Held After
98,090
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
129
Price
$320.01
Total Value
$41.28K
Shares Held After
98,364
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
135
Price
$319.03
Total Value
$43.07K
Shares Held After
98,493
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
34,297
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
34,505
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
34,777
% of Holdings
2.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
35,544
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
35,894
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
36,183
% of Holdings
0.6%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
808
Price
$9.06
Total Value
$7.32K
Shares Held After
189,669
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
36,398
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
36,500
% of Holdings
0.3%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
8,233
Price
$35.99
Total Value
$296.35K
Shares Held After
2,231
% of Holdings
78.7%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
201
Price
$80.00
Total Value
$16.08K
Shares Held After
4,347
% of Holdings
4.4%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
238
Price
$80.00
Total Value
$19.04K
Shares Held After
4,347
% of Holdings
5.2%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
200
Price
$80.00
Total Value
$16.00K
Shares Held After
36,330
% of Holdings
0.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
139
Price
$17.96
Total Value
$2.50K
Shares Held After
22,554
% of Holdings
0.6%
Nautilus Biotechnology, Inc. (NAUT)
Patel Sujal M — Director
Shares
25,000
Price
$2.61
Total Value
$65.24K
Shares Held After
10,366,721
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
200
Price
$73.26
Total Value
$14.65K
Shares Held After
209,773
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,075
Price
$71.98
Total Value
$149.36K
Shares Held After
209,973
% of Holdings
1.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
3,225
Price
$70.33
Total Value
$226.81K
Shares Held After
212,048
% of Holdings
1.5%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
2,631
Price
$18.73
Total Value
$49.29K
Shares Held After
339,392
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
3,413
Price
$208.80
Total Value
$712.62K
Shares Held After
21,662
% of Holdings
13.6%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
2,457
Price
$207.91
Total Value
$510.82K
Shares Held After
25,075
% of Holdings
8.9%
Showing 751–800 of 1217 transactions (page 16 of 25)